Closed
SectorHealthcare
144.14 0.35
24h
Min
143.48
Max
144.4
Income | 100M 108M |
|---|---|
Sales | 115M 688M |
P/E Sector Avg | 41.446 37.461 |
Profit margin | 15.636 |
Employees | 1,800 |
EBITDA | 129M 153M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +17.55% upside |
Next Earnings | 28 paź 2025 |
|---|
Market Cap | 785M 14B |
|---|---|
Previous open | 143.79 |
Previous close | 144.14 |
By Acuity
21%
79%
37 / 371 Ranking in Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 169.27 USD 17.55%
High 200 USD
Low 124 USD
Based on 25 Wall Street analysts offering 12 month price targets forNeurocrine Biosciences Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$